Patent details
300745 Product Name: Combinatie van levend verzwakt Bovien Viraal Diarree Virus 1 (BVDV-1), niet-cytopathogeen, wild-type stam KE-9, dat een deletie in de coderende sequentie voor glycoproteïne Erns en een deletie in de coderende sequentie voor Npro heeft, waarbij de deletie in de coderende sequentie voor glycoproteïne Erns leidt tot inactivering van de in Erns aanwezige RNase-activiteit en de deletie in de coderende sequentie voor Npro leidt tot inactivering van het Npro en levend verzwakt Bovien Viraal Diarree Virus 2 (BVDV-2), niet-cytopathogeen, wild-type stam NY-93, dat een deletie in de coderende sequentie voor glycoproteïne Erns en een deletie in de coderende sequentie voor Npro heeft, waarbij de deletie in de coderende sequentie voor glycoproteïne Erns leidt tot inactivering van de in Erns aanwezige RNase-activiteit en de deletie in de coderende sequentie voor Npro leidt tot inactivering van het Npro
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300745
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1751276
- Status:
- SPC in force
- Application number:
- 300745
- Procedural language:
- Dutch
- First Applicant Residence Country:
Marketing Authorization
- Marketing Authorization Number:
- EU/2/14/176
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 29/12/2014
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 16/06/2015
- First Marketing Authorization date:
- 29/12/2014
- Grant date:
- 26/01/2016
- Activation date:
- 18/05/2025
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 16/06/2015
- SPC/SPC Extension Expiration Date:
- 28/12/2029
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 16/06/2015
- Name:
- Boehringer Ingelheim Vetmedica GmbH
- Address:
- Binger Strasse 173, 55216, Ingelheim, Germany (DE)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 16/06/2015
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC
- Journal edition number:
- 21/25
- Publication date:
- 21/05/2025
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 04/16
- Publication date:
- 27/01/2016
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 2015/26
- Publication date:
- 24/06/2015
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Other
- Note:
Annual Fee
- Annual Fee(s) Due Date:
- 31/05/2026
- Annual Fee Number:
- 22
- Annual Fee Amount:
- 1800 Euro
- Last Annual Payment Date:
- 12/05/2025
- Last Annual Fee Paid Number:
- 21
- Last Annual Fee Paid Amount:
- 1600 Euro
- Payer:
- Dennemeyer and Co
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 06/07/2020 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /5/4/7/0/0/0400300745/docs/300745_3_incomingcorrespondencepaper20210319111757881.pdf | ||
| 20/04/2020 | SPC Documents | Annex SPC | 6 | /5/4/7/0/0/0400300745/docs/300745_2_supplprotectioncertificate20201207030206351.pdf | ||
| 20/04/2020 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /5/4/7/0/0/0400300745/docs/300745_10_incomingcorrespondencepaper20210319111535231.pdf | ||
| 26/01/2016 | SPC Documents | Certificate SPC | 1 | /5/4/7/0/0/0400300745/docs/300745_9_supplprotectioncertificate20201204051507086.pdf | ||
| 26/01/2016 | Outgoing Correspondence | Decision grant | 2 | /5/4/7/0/0/0400300745/docs/300745_13_outgoingcorrespondence20201204051748613.pdf | ||
| 08/12/2015 | Incoming Correspondence Paper | Incoming Correspondence Paper | 2 | /5/4/7/0/0/0400300745/docs/300745_1_incomingcorrespondencepaper20151214124359751.pdf | ||
| 13/08/2015 | Outgoing Correspondence | Outgoing Letter | 4 | /5/4/7/0/0/0400300745/docs/300745_5_outgoingcorrespondence20150813.pdf | ||
| 17/06/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /5/4/7/0/0/0400300745/docs/300745_12_outgoingcorrespondence20150617.pdf | ||
| 16/06/2015 | Application Form | First filed application form | 5 | /5/4/7/0/0/0400300745/docs/300745_0_applicationform20150616.pdf | ||
| 16/06/2015 | SPC Documents | Marketing Authorization SPC | 3 | /5/4/7/0/0/0400300745/docs/300745_4_supplprotectioncertificate20201204050857942.pdf | ||
| 16/06/2015 | SPC Documents | Annex SPC | 1 | /5/4/7/0/0/0400300745/docs/300745_6_supplprotectioncertificate20201204050706754.pdf | ||
| 16/06/2015 | SPC Documents | Annex SPC | 6 | /5/4/7/0/0/0400300745/docs/300745_7_supplprotectioncertificate20201204050706680.pdf | ||
| 16/06/2015 | SPC Documents | Summary of the characteristics of the product | 6 | /5/4/7/0/0/0400300745/docs/300745_8_supplprotectioncertificate20201204050357727.pdf | ||
| 16/06/2015 | SPC Documents | Accompanying letter SPC | 2 | /5/4/7/0/0/0400300745/docs/300745_11_supplprotectioncertificate20201204052311890.pdf |